How many analysts have analysed CEMENTOS PACASMAYO SAA - ADR (CPAC)?
The number of analysts covering CEMENTOS PACASMAYO SAA - ADR (CPAC) is 13.
CEMENTOS PACASMAYO SAA - ADR (CPAC) Forecast, Price Target & Analyst Ratings
NYSE:CPAC • US15126Q2084
Current stock price
10.4 USD
+0.4 (+4%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CEMENTOS PACASMAYO SAA - ADR (CPAC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q3 / 2021
- EPS Estimate
- PEN0.13
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $10.40 to mean target of N/A, Based on 13 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.77%
CPAC was analyzed by 13 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about CPAC.
In the previous month the buy percentage consensus was at a similar level.
CPAC was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-12-19 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-11-04 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-06-04 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-08-21 | JP Morgan | Downgrade | Neutral -> Underweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q3 / 2021
- EPS Estimate
- PEN0.13
- Revenue Estimate
- N/A
- Revenue Q2Q
- N/A
- EPS Q2Q
- 199.47%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2020 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.22B -1.66% | 1.262B 3.50% | 1.393B 10.33% | 358.839M -74.23% | 415.59M 15.82% | 451.825M 8.72% | 499.755M 10.61% | 1.802B 260.58% | 2.175B 20.70% | 2.212B 1.70% | 2.124B -3.98% | 2.201B 3.63% | 2.275B 3.36% | 2.351B 3.34% | |
| EBITDA YoY % growth | 370.306M -4.45% | 366.953M -0.91% | 402.546M 9.70% | N/A | N/A | N/A | N/A | 493.87M | 596.65M 20.81% | 597.47M 0.14% | 590.95M -1.09% | 616.99M 4.41% | 642.25M 4.09% | 669.46M 4.24% | |
| EBIT YoY % growth | 246.1M -10.92% | 237.174M -3.63% | 272.728M 14.99% | N/A | N/A | N/A | N/A | 368.02M | 433.08M 17.68% | 424.38M -2.01% | N/A | N/A | N/A | N/A | |
| Operating Margin | 20.18% | 18.79% | 19.58% | N/A | N/A | N/A | N/A | 20.42% | 19.91% | 19.19% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 13.44% | 0.27 -39.29% | N/A 137.14% | 0.27 -58.83% | 0.53 101.30% | 0.59 10.66% | 0.90 52.92% | 0.90 | N/A | N/A | N/A | N/A | N/A | N/A |
All data in PEN
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 21 | Q4 / 21 | |
|---|---|---|
| EPS Q2Q % growth | 0.13 199.47% | 0.14 194.06% |
| Revenue Q2Q % growth | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in PEN
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A